LeXin Medical: The company's application for the registration of a blood glucose meter medical device has been accepted.

LeXin Medical announced that it has recently received a notification from the Guangdong Drug Administration Bureau stating that the company's application for the registration of a blood glucose meter medical device has been accepted. The product consists of a portable mainframe and software, designed for use by diabetes patients at home to quantitatively test the glucose concentration in fresh venous whole blood samples and capillary whole blood samples of adults, monitoring the effectiveness of blood sugar control. The blood glucose meter GBZ41-B has Bluetooth functionality, allowing measurement results to be uploaded to a designated app. The acceptance of this medical device registration will help the company expand its domestic business, enhance market expansion capabilities, and promote the application of products in the field of remote chronic disease management.